Pfizer gets PDUFA for Hemophilia B Gene Therapy.
While Pfizer has been under pressure over weight loss drug lead taken by Eli Lilly, the positive factor is that they have received the PDUFA for their Hemophilia B gene therapy. The PDUFA date is in 2024 and I think that will be a major catalyst. Personally I think Pfizer is a DCA candidate.
Please subscribe: / @sharetreck
The videos in this channel should not be construed as financial advice. Always make sure to do your own due diligence and research.
Please do not trade or invest based on this video. Information provided in this video is not investment advice and is for entertainment purposes only.
Disease and therapy details are derived from news articles and publications by companies or research organizations. I am not a doctor but am only facilitating dissemination of published information.